![]() AMLo Biosciences AMLo Biosciences is a company that develops a prognostic test for early-stage cutaneous melanoma. | ||
Founding Date | Founding Date 2012 | Founding Date 2017 |
Type | Type Private | Type Private |
Tags | ||
Locations | Locations Sydney, AU HQ | Locations Newcastle upon Tyne, GB HQ Newcastle Upon Tyne, GB Newcastle Upon Tyne, GB |
Employees | Employees 1184% increase | Employees 209% decrease |

AMLo Biosciences is a company that develops a prognostic test for early-stage cutaneous melanoma.
View company